JMP Securities reaffirmed their market outperform rating on shares of Rezolute (NASDAQ:RZLT – Free Report) in a research report released on Thursday, Benzinga reports. They currently have a $7.00 price target on the stock. RZLT has been the subject of several other reports. HC Wainwright reiterated a buy rating and set a $14.00 target price […]

Related Keywords

Manhattan , New York , United States , Myoung Jin Kim , Daron Evans , Securities Exchange Commission , Rezolute Company Profile , First Manhattan Co , Maxim Group , Hermes Inc , Vivo Capital , Nantahala Capital Management , Rezolute Inc , Free Report , Get Free Report , Exchange Commission , Director Young Jin Kim , Capital Management , Rezolute Daily , Rezolute , Nasdaq Rzlt , Rzlt , Medical , Reiterated Rating , Jmp Securities ,